Soumya Kanti Ghosh is the Group Chief Economic Advisor at State Bank of India. He has previously worked with Tata AIA, American Express and ICRA.
Dr. Ghosh has contributed to pioneering research on India’s payroll data and provided inputs into key government initiatives including PM-KISAN and ECLGS. He has served on the 16th Finance Commission and is a member of the Prime Minister’s Economic Advisory Council (PMEAC), as well as several government committees on economic statistics and index revisions.
He is Chairman of the Indian Banks’ Association’s Economist Group, a member of the Editorial Advisory Board of the Indian Institute of Banking and Finance, and a Distinguished Fellow at InfraVision Foundation.
For eight consecutive years through 2025, he has been ranked among India’s Best Individuals in Research by The Asset. His research is widely published in leading domestic and international journals, and he is a regular commentator on economic and policy issues across print and electronic media. SBI Research under his leadership has consistently delivered highly accurate forecasts across key economic indicators.
Dr. Ghosh holds an undergraduate degree from Kolkata University, a postgraduate degree from Delhi School of Economics, and a doctorate from JNU.
Two of Mumbai's defining industries — BFSI and pharma — are being reshaped by the same global forces, but they're feeling them in very different ways. In banking, insurance and fintech, AI is rewriting roles faster than hiring plans can keep up, risk and compliance talent is scarce, and new-economy players compete hard for the same data and technology skills. In pharma, the pressure is compounded by a shifting trade landscape: US tariffs on pharmaceutical imports are pushing Indian drugmakers to rethink where they manufacture and hire, even as AI reshapes drug discovery and global capability centres pull niche R&D and regulatory talent into India.
In this session, senior economists decode what large-scale hiring data actually reveals about where these two sectors are headed. Drawing on Indeed's Hiring Lab research — millions of job postings across 60+ labour markets — alongside deep academic insight, they'll unpack which roles and skills are ascending in BFSI and pharma, how trade and tariff pressure is reshaping pharma's talent map.
Knowledge Partner
Join us for two days of learning, discovery, and The Human Advantage in action across Bengaluru and Mumbai. Limited seats are available.
Register Now